Table 1 Clinical and laboratory features of patients CNO
From: Chronic nonbacterial osteomyelitis in children: a retrospective multicenter study
Patient | Sex (mm/ h) | Age | ESR | Course | Immun-suppressives | TNF | Bisphosphonates | Follow up |
|---|---|---|---|---|---|---|---|---|
1 | M | 4.7y | 32 | Relapsing | No | No | No | 5.8y |
2 | F | 9.6y | 12 | Persistent | No | No | No | 0.7y |
3 | M | 1.4y | 83 | Persistent | MTX | No | Neridronat | 8.7y |
4 | F | 11.4y | 16 | Relapsing | No | No | No | 3.8y |
5 | M | 10.1y | 38 | Persistent | MTX | No | Neridronat | 0.8y |
6 | F | 8.3y | 8 | Persistent | MTX | No | No | 2.5y |
7 | F | 7.5y | 46 | Acute | No | No | No | |
8 | F | 1.9y | 30 | Acute | No | No | No | 15y |
9 | F | 13.8y | 25 | Persistent | - | - | - | 1.9y |
10 | M | 9.5y | 49 | Relapsing | Steroids | No | No | 7y |
11 | F | 10.5y | 54 | Relapsing | Steroids | No | PAM | 2.6y |
12 | F | 4.1y | 61 | Relapsing | No | No | No | 7.1y |
13 | F | 8.8y | 35 | Relapsing | Steroids | Yes | PAM | 10y |
14 | F | 12.5y | 7 | Relapsing | No | Yes | No | 4.8y |
15 | F | 12.0y | 60 | Persistent | No | Yes | No | 10.3y |
16 | F | 12.5y | 57 | Acute | No | No | No | 0.9y |
17 | F | 9.0y | - | Persistent | Steroids | yes | PAM/Alendronat | 5y |
18 | M | 11.7y | 56 | Persistent | No | No | No | 2y |
19 | M | 15.8y | 18 | Acute | No | No | No | 6.3y |
20 | F | 11.4 y | 5 | Persistent | Steroids/MTX | No | No | 1.5y |
21 | F | 11.5y | 19 | Persistent | Yes | No | No | 1.7y |
22 | F | 9.9y | 17 | Persistent | No | No | No | 7.5y |
23 | F | 6.0y | 6 | Persistent | No | No | No | 13y |
24 | F | 10.5y | 34 | Persistent | Steroids/MTX | No | No | 8y |
25 | F | 9.9y | 40 | Acute | No | No | No | 0.8y |
26 | F | 11.5y | 35 | Persistent | No | Yes | No | 2.4y |
27 | M | 15.3y | 8 | Persistent | No | No | No | 1.6y |
28 | F | 10.5y | 20 | Persistent | No | No | No | 4.2y |
29 | M | 8.5y | 55 | Persistent | No | No | No | 0.5y |
30 | F | 9.2y | 42 | Persistent | No | No | No | 3y |
31 | F | 14.7y | 18 | Persistent | No | No | No | 2.8y |
32 | F | 8.9y | 36 | Persistent | No | No | No | 4.8y |
33 | F | 9.3y | 52 | Persistent | No | No | No | 1.2y |
34 | F | 7.5y | 33 | Acute | No | No | No | 6.3y |
35 | F | 8.9y | 43 | Persistent | MTX | Yes | No | 5.5y |
36 | F | 1.8y | - | Persistent | MTX | No | No | 1.y |
37 | M | 8.7y | 31 | Persistent | No | No | No | 0.8y |
38 | F | 6.1y | 21 | Persistent | Steroids/MTX | Yes | No | 7.5y |
39 | F | 9.5y | 6 | Persistent | No | No | No | 1.3y |
40 | M | 5.8y | 53 | Relapsing | Steroids/MTX | Yes | No | 2.1y |
41 | F | 10.3y | 62 | Persistent | Steroids/MTX | No | No | 1.9y |